U.S. University Establishing Medical Cannabis Patient Outcomes Database

0
292

Thomas Jefferson University’s Lambert Center for the Study of Medicinal Cannabis and Hemp has announced the creation of the mmj.org initiative, which will involve a 100,000 patient database.

There’s little to see on MMJ.org currently, but within the next couple of months a call will go out to medical cannabis users in the USA to share their health outcomes.

“We are launching the mmj.org patient registry to fill significant gaps in the science with the largest longitudinal study ever of patient-reported outcomes with medical marijuana,” said Steven K. Klasko, MD, MBA, president and CEO of Thomas Jefferson University and Jefferson Health.

The University says the initiative will be the most comprehensive clinical database yet compiled in the field of medical marijuana.

The broader goals of the initiative are to advance the science related to medical marijuana and provide patients and all stakeholders with practical evidence-based resources.

The Lambert Center currently offers two accredited medicinal cannabis related activities; one being a course designed for healthcare professionals seeking Pennsylvania Department of Health approval to recommend or dispense medicinal cannabis in that state. The second is an accredited CE course, Expert Update in Therapeutic Uses of Cannabinoids, geared towards those interested in brushing up on medicinal cannabis but not requiring DoH certification.

If the name “Lambert” sounds familiar to Australians, that’s because Australian philanthropists Barry and Joy Lambert donated USD $3M Thomas Jefferson University to support its Center for Medical Cannabis Education and Research, which appears to have been renamed.

The Lamberts also bestowed a whopping $33.7 million gift to the University of Sydney in Australia to fund the Lambert Initiative; part of which includes the PELICAN project.

The issue of medical cannabis is a particularly important one to the Lamberts as their granddaughter Katelyn has benefited from it. Katelyn was diagnosed with Dravet Syndrome, previously known severe myoclonic epilepsy of infancy (SMEI). It’s a type of epilepsy characterized by prolonged febrile and non-febrile seizures within the first year of a child’s life, cognitive impairment, behavioral disorders, and motor deficits.

By: Terry Lassitenaz, Hempgazette

NO COMMENTS

LEAVE A REPLY